New blood test could spot fetal chromosome issues weeks earlier
NCT ID NCT06523543
First seen Mar 17, 2026 · Last updated Jun 16, 2026 · Updated 16 times
Summary
This study aims to see if a new, ultra-early, non-invasive test can accurately detect fetal chromosomal abnormalities using cells from the placenta. Researchers will enroll 25 pregnant women between 7 and 16 weeks of pregnancy. The goal is to develop a safer, earlier alternative to current prenatal diagnostic methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Montpellier
RECRUITINGMontpellier, France, 34295, France
Contact
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.